TBI-223 is an orally bioavailable oxazolidinone antibiotic and an antimicrobial. TBI-223 shows activity against Mycobacterium tuberculosis (Mtb)[1][2].
[1]. Chauhan A, et al. Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs. Life Sci. 2021;274:119301.
[2]. Motamen S, et al. Analysis of Approaches to Anti-tuberculosis Compounds. ACS Omega. 2020;5(44):28529-28540. Published 2020 Oct 27.
















